San Francisco, CA—Percutaneous closure of the patent ductus arteriosus (PDA) in children using a novel device is safe and effective, according to a prospective study presented in a featured clinical ...
Nicklaus Children's Heart Institute Launches Bedside Transcatheter PDA Closure Offering for Newborns
New innovative capability brings lifesaving cardiac care directly to the NICU, reducing risks associated with transporting fragile premature infants. MIAMI , Sept. 22, 2025 /PRNewswire/ -- Nicklaus ...
In 2019, the U.S. Food and Drug Administration approved the first PDA occlusion device for infants as small as 700 grams, leading to rapid adoption of tcPDA in premature infants. Catheter-based ...
“This position statement represents a collective effort between neonatology, anesthesia, and interventional cardiology to provide comprehensive guidance on tcPDA device occlusion that can be adapted ...
Hosted on MSN
New guidance released to improve safety and outcomes of patent ductus arteriosus closure in premature infants
Transcatheter PDA closure has been a mainstay in congenital interventional cardiology for decades, but very low birth weight infants were once excluded due to access challenges and the lack of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results